1. Dual antitumour effect of 5-azacytidine by inducing a breakdown of resistance-mediating factors and epigenetic modulation. Issue 2 (23rd November 2010) Authors: Venturelli, Sascha; Berger, Alexander; Weiland, Timo; Zimmermann, Martina; Häcker, Sabine; Peter, Christoph; Wesselborg, Sebastian; Königsrainer, Alfred; Weiss, Thomas S; Gregor, Michael; Fulda, Simone; Lauer, Ulrich M; Bitzer, Michael Journal: Gut Issue: Volume 60:Issue 2(2011) Page Start: 156 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. TGF-β2 silencing to target biliary-derived liver diseases. Issue 9 (28th January 2020) Authors: Dropmann, Anne; Dooley, Steven; Dewidar, Bedair; Hammad, Seddik; Dediulia, Tatjana; Werle, Julia; Hartwig, Vanessa; Ghafoory, Shahrouz; Woelfl, Stefan; Korhonen, Hanna; Janicot, Michel; Wosikowski, Katja; Itzel, Timo; Teufel, Andreas; Schuppan, Detlef; Stojanovic, Ana; Cerwenka, Adelheid; Nittka,... Journal: Gut Issue: Volume 69:Issue 9(2020) Page Start: 1677 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗